title: Holmium laser enucleation for large (greater than 100 mL) prostate glands.
abstract: BACKGROUND
  To evaluate the holmium laser enucleation of the prostate (HoLEP) using the transurethral soft tissue morcellator (TUSTM), as a primary surgical treatment for symptomatic benign prostatic hyperplasia (BPH) with prostate glands > 100 mL.
  
  
  METHODS
  Eighteen patients with preoperative prostate volumes > 100 mL underwent the HoLEP procedure. The criteria for surgery were determined by a preoperative International Prostate Symptom Score (IPSS), a prior failure of medical therapy, and urinary retention.
  
  
  RESULTS
  The mean preoperative IPSS and prostate gland size were 13.8 and 142.3 mL, respectively. The total energy used by the laser was 288.4 kJ. The mean catheter time was 23.8 h and, perioperatively, no patients had electrolyte abnormalities or required blood transfusions. The 3-week postoperative IPSS was 2.8, with minimum long-term complications.
  
  
  CONCLUSIONS
  Holmium laser enucleation of the prostate with TUSTM is a safe and effective alternative to open prostatic surgery for glands > 100 mL.
authors.affiliation: Department of Urology, New York Medical College, Valhalla 10595, USA.
authors.forename: Janaka A
authors.initials: JA
authors.lastname: Hettiarachchi
authors.forename: Albert A
authors.initials: AA
authors.lastname: Samadi
authors.forename: Sensuke
authors.initials: S
authors.lastname: Konno
authors.forename: Akhil K
authors.initials: AK
authors.lastname: Das
mesh_terms: D000368:Aged; D005500:Follow-Up Studies; D006695:Holmium; D006801:Humans; D053685:Laser Therapy / Q000379:methods*; D008297:Male; D011470:Prostatic Hyperplasia / Q000601:surgery*; D016896:Treatment Outcome
chemical_list: D006695:Holmium